Showing results (491-500 of 1,106) with videos related to
Sort By:
Pageof 111
European Heart Journal|April 23, 2015
Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trialsChirag Bavishi, Franz H Messerli, Bernard Kadosh, et al.Journal of the American Heart Association|April 7, 2023
Twenty-Four-Hour Blood Pressure-Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double-Blind Multicenter StudyKazuomi Kario, Hiromi Rakugi, Daisuke Yarimizu, et al.American Journal of Hypertension|April 3, 2025
Efficacy of Esaxerenone Plus a Renin-Angiotensin System Inhibitor or Calcium Channel Blocker for Nocturnal Hypertension: A Post Hoc AnalysisKazuomi Kario, Sadayoshi Ito, Hiroshi Itoh, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|August 4, 2007
Masked hypertension in diabetes mellitus: a potential riskKazuo Eguchi, Joji Ishikawa, Satoshi Hoshide, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|January 20, 2020
The first study comparing a wearable watch-type blood pressure monitor with a conventional ambulatory blood pressure monitor on in-office and out-of-office settingsKazuomi Kario, Daichi Shimbo, Naoko Tomitani, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|November 6, 2024
Cost-Effectiveness of Radiofrequency Renal Denervation for Uncontrolled Hypertension in JapanKazuomi Kario, Khoa N Cao, Yuji Tanaka, et al.Journal of Cardiology|May 19, 2019
Association of calciprotein particles measured by a new method with coronary artery plaque in patients with coronary artery disease: A cross-sectional studyJun Nakazato, Satoshi Hoshide, Minoru Wake, et al.American Journal of Nephrology|August 24, 2013
Both chronic kidney disease and nocturnal blood pressure associate with strokes in the elderlyYuichiro Yano, George L Bakris, Kunihiro Matsushita, et al.Atherosclerosis|January 19, 2011
Association between aldosterone induced by antihypertensive medication and arterial stiffness reduction: the J-CORE studyYoshio Matsui, Kazuo Eguchi, Michael F O'Rourke, et al.Hypertension (Dallas, Tex. : 1979)|May 2, 2012
Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy StudyYoshio Matsui, Michael F O'Rourke, Satoshi Hoshide, et al.Pageof 111